These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34794485)

  • 21. Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia.
    Khan AR; Alothaim A; Alfares A; Jowed A; Enazi SMA; Ghamdi SMA; Seneid AA; Algahtani A; Zahrani SA; AlFadhel M; Aldibasi O; AlOmair LA; Bajudah R; Alanazie AN
    Ann Saudi Med; 2022; 42(2):107-118. PubMed ID: 35380063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplicon sequencing-based carrier screening for 170 monogenic disorders among children with abnormal LC-MS/MS results.
    Chen X; Xu Z; Lei X; Liang H; Wu F; Chen R; Guo Y; Xiong L
    Clin Chim Acta; 2023 Jan; 539():274-277. PubMed ID: 36574877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of methylmalonic acid, 2-methylcitric acid, and total homocysteine in dried blood spots by liquid chromatography-tandem mass spectrometry: A reliable follow-up method for propionylcarnitine-related disorders in newborn screening.
    Hu Z; Yang J; Lin Y; Wang J; Hu L; Zhang C; Zhang Y; Huang X
    J Med Screen; 2021 Jun; 28(2):93-99. PubMed ID: 32615850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
    Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
    Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China.
    Ma S; Guo Q; Zhang Z; He Z; Yue A; Song Z; Zhao Q; Wang X; Sun R
    J Clin Lab Anal; 2020 May; 34(5):e23159. PubMed ID: 31916308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Newborn screening for primary carnitine deficiency and variant spectrum of SLC22A5 gene in Guangzhou].
    Huang YL; Tang CF; Liu SC; Sheng HY; Tang F; Jiang X; Zheng RD; Mei HF; Liu L
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):476-481. PubMed ID: 32521959
    [No Abstract]   [Full Text] [Related]  

  • 30. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.
    Hassan FA; El-Mougy F; Sharaf SA; Mandour I; Morgan MF; Selim LA; Hassan SA; Salem F; Oraby A; Girgis MY; Mahmoud IG; El-Badawy A; El-Nekhely I; Moharam N; Mehaney DA; Elmonem MA
    J Med Screen; 2016 Sep; 23(3):124-9. PubMed ID: 26790708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Maruyama S; Noguchi A; Awaya T; Ishige M; Ishige N; Musha I; Ajihara S; Ohtake A; Naito E; Hamada Y; Kono T; Asada T; Sasai H; Fukao T; Fujiki R; Ohara O; Bo R; Yamada K; Kobayashi H; Hasegawa Y; Yamaguchi S; Takayanagi M; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2017 Nov; 122(3):67-75. PubMed ID: 28801073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.
    Frazier DM; Millington DS; McCandless SE; Koeberl DD; Weavil SD; Chaing SH; Muenzer J
    J Inherit Metab Dis; 2006 Feb; 29(1):76-85. PubMed ID: 16601872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-generation sequencing based newborn screening and comparative analysis with MS/MS.
    Shen G; Li W; Zhang Y; Chen L
    BMC Pediatr; 2024 Apr; 24(1):230. PubMed ID: 38561707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The modern face of newborn screening.
    Chien YH; Hwu WL
    Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S22-S29. PubMed ID: 36481189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening.
    Chen T; Fan C; Huang Y; Feng J; Zhang Y; Miao J; Wang X; Li Y; Huang C; Jin W; Tang C; Feng L; Yin Y; Zhu B; Sun M; Liu X; Xiang J; Tan M; Jia L; Chen L; Huang H; Peng H; Sun X; Gu X; Peng Z; Zhu B; Zou H; Han L
    JAMA Netw Open; 2023 Sep; 6(9):e2331162. PubMed ID: 37656460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
    Hong X; Kumar AB; Ronald Scott C; Gelb MH
    Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.